TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | 1 | 8 | 15 | 11 | -59 | -4 |
| S | %wins | 67 | 67 | 0 | 33 | 33 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 21:58 | 5/16/24 | GRTS | Gritstone Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Allen Andrew R | CA | DO | P,CEO | S.d | -18 | 0.7483 | 0 | -24 | -1 | 2,435 | D | ||||||||||||||
1/21/15 21:09 | 1/15/15 | CLVS | Clovis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allen Andrew R | CO | O | See Rema | S.am | -5,270 | 65.87 | 33 | -80 | -44 | 102 | D | 256 | -6 | 83 | 41 | 34 | 22 | 16 | 7 | -1 | 3 | 13 | 29 | 29 | -65 |
1/20/15 21:11 | 1/15/15 | CLVS | Clovis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allen Andrew R | CO | O | See Rema | S.m | -5,251 | 65.64 | 33 | -80 | -44 | 102 | D | 253 | -9 | 80 | 44 | 39 | 20 | 16 | 10 | -3 | 0 | 8 | 26 | 26 | -69 |
6/7/13 17:04 | 6/5/13 | CLVS | Clovis Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Allen Andrew R | CO | O | See Rema | S | -1,549 | 68.54 | 32 | -23 | -11 | 182 | I | 314 | 356 | 183 | 94 | 97 | 107 | -3 | 2 | -1 | 4 | -11 | -22 | -44 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |